Helliwell, James Allen — Insider Profile

Insider Profile

Helliwell, James Allen

🔒 Follow — get an alert on any new filing

$EPRX

Companies Filed At

Open-Market Buys (2yr)

—

Buy Value (2yr, open-market)

Jun 15, 2026

Most Recent Trade

Credibility
Score

82%

Hit Rate

+127.1%

Avg 90d Return

+88.7%

Median 90d Return

Evaluated Trades

+285.7%

Best Trade

-39.3%

Worst Trade

Hit rate and returns are based on 11 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.

Cross-Company Track Record

89%

Hit Rate · 90d

+116.7%

Median Alpha · 90d

Closed Buys Evaluated

89%

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

cluster buyer high frequency size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 9 closed buys with individual return outcomes available on the Research plan.

Political Donations · Elections Canada

$1K in individual political contributions across 2 donations (2022–2023).

Date	Party	Recipient	Amount
2023-09-12	Conservative Party of Canada	Conservative Party of Canada	$650
2022-12-22	Conservative Party of Canada	Conservative Party of Canada	$400

Source: Elections Canada public contribution records (individual donations only; corporate political donations have been banned federally since 2007). Matched to this insider by name — shown for transparency, not a claim of wrongdoing and not a Confluence Score input.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jun 15, 2026	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	104,500	—	—	62
Jun 15, 2026	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	351,500	$8.45	$3.0M	62
May 05, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	150,000	$0.76	$114K	62
May 05, 2026	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	150,000	$0.76	$114K	62
Nov 06, 2025	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	100,500	$0.75	$75K	62
Nov 06, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	100,500	—	—	62
Nov 06, 2025	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	100,500	—	—	62
Nov 06, 2025	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Buy	100,500	$0.50	$50K	62
Nov 06, 2025	$EPRX Eupraxia Pharmaceuticals	—	Exercise	Sell	100,500	$0.50	$50K	62
Nov 02, 2025	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	18,750	$8.00	$150K	62
Mar 31, 2025	$EPRX Eupraxia Pharmaceuticals	—	Expiry	Sell	50,000	$8.00	$400K	62
Mar 25, 2025	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	260,000	$5.14	$1.3M	62
May 13, 2024	$EPRX Eupraxia Pharmaceuticals	—	Comp. Grant	Buy	400,000	$3.96	$1.6M	62
Aug 18, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Sell	14,286	$7.00	$100K	62
Mar 28, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	4,800	$4.10	$20K	62
Mar 28, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	600	$4.11	$2K	62
Mar 28, 2023	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	700	$4.14	$3K	62
Aug 22, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	6,800	$1.15	$8K	62
Aug 19, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	700	$1.10	$770	62
Aug 18, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	8,500	$1.05	$9K	62
Aug 17, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	2,500	$1.05	$3K	62
Jun 29, 2022	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	9,900	$1.00	$10K	62
Mar 09, 2021	$EPRX Eupraxia Pharmaceuticals	—	Open Market	Buy	168,750	$8.00	$1.4M	62

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.